{"ticker": {"uuid": "f1224815-cddd-4bfb-8dc3-fe2858461148", "symbol": "LGND", "name": "Ligand Pharmaceuticals Incorporated", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates", "summary": "Orchestra BioMed Holdings, Inc. The BACKBEAT global pivotal trial (\"BACKBEAT Trial\"), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable randomized patients by end of Q3 2026, with primary data presentation targeted for Q2 2027, assuming those endpoints are met. Virtue pivotal trial is advancing with further site activations and patient enrollments. $110 million cash balance provides projected runway into Q4 2027 and through key upcoming milestones, following $35 million in strategic capital from Medtronic and Ligand. Company to host R&D Day on November", "url": "https://finance.yahoo.com/healthcare/articles/orchestra-biomed-reports-second-quarter-201200454.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T20:12:00+00:00", "published_display": "10 Aug 2026 20:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.227, "duplicate_count": 1, "topics": ["Biotech", "Cardiovascular", "Clinical Trials", "Fda Approval", "Financial Results", "Institutional Investors"]}, {"title": "LGND: XOMA Acquisition Closed", "summary": "By John Vandermosten, CFA NASDAQ: LGND READ THE FULL LGND RESEARCH NOTE Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported second quarter 2026 results boasting total revenue and income of $63.7 million, a 34% year over year increase. Adjusted core earnings per share (EPS) of $2.37 were also impressive, rising 48%. By line item, royalties rose 32%, and contract revenue increased by 161%. Captisol was the odd man out, with a revenue decline of 4% due to timing of customer orders. Since Ligand's May financial update, the company has executed a $700 million convertible debt financing and closed ", "url": "https://finance.yahoo.com/healthcare/articles/lgnd-xoma-acquisition-closed-092700005.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T09:27:00+00:00", "published_display": "10 Aug 2026 09:27", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.233, "duplicate_count": 1, "topics": ["Acquisition", "Balance Sheet", "Debt Financing", "Earnings", "Earnings Per Share", "M A"]}], "by_tier": {"direct": [{"title": "Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates", "summary": "Orchestra BioMed Holdings, Inc. The BACKBEAT global pivotal trial (\"BACKBEAT Trial\"), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable randomized patients by end of Q3 2026, with primary data presentation targeted for Q2 2027, assuming those endpoints are met. Virtue pivotal trial is advancing with further site activations and patient enrollments. $110 million cash balance provides projected runway into Q4 2027 and through key upcoming milestones, following $35 million in strategic capital from Medtronic and Ligand. Company to host R&D Day on November", "url": "https://finance.yahoo.com/healthcare/articles/orchestra-biomed-reports-second-quarter-201200454.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T20:12:00+00:00", "published_display": "10 Aug 2026 20:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.227, "duplicate_count": 1, "topics": ["Biotech", "Cardiovascular", "Clinical Trials", "Fda Approval", "Financial Results", "Institutional Investors"]}, {"title": "LGND: XOMA Acquisition Closed", "summary": "By John Vandermosten, CFA NASDAQ: LGND READ THE FULL LGND RESEARCH NOTE Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported second quarter 2026 results boasting total revenue and income of $63.7 million, a 34% year over year increase. Adjusted core earnings per share (EPS) of $2.37 were also impressive, rising 48%. By line item, royalties rose 32%, and contract revenue increased by 161%. Captisol was the odd man out, with a revenue decline of 4% due to timing of customer orders. Since Ligand's May financial update, the company has executed a $700 million convertible debt financing and closed ", "url": "https://finance.yahoo.com/healthcare/articles/lgnd-xoma-acquisition-closed-092700005.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T09:27:00+00:00", "published_display": "10 Aug 2026 09:27", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.233, "duplicate_count": 1, "topics": ["Acquisition", "Balance Sheet", "Debt Financing", "Earnings", "Earnings Per Share", "M A"]}], "industry": [], "sector": []}, "total_fetched": 2, "total_unique": 2, "total_relevant": 2, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "healthy", "calls_used": 40, "call_budget": 500, "budget_used_pct": 8.0, "requests_made": 8, "last_success_at": "2026-08-13T00:46:08.072252+00:00", "newest_seen_at": "2026-08-13T00:07:59+00:00", "rate_limit": 1200, "rate_remaining": 1198, "last_error": "", "mapped_mentions": 3604, "unmapped_mentions": 1784}, "status": "healthy"}, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 0, "score": 63, "raw_score": 78, "total": 2, "evidence_count": 2, "effective_articles": 2.0, "direct_story_count": 2, "industry_story_count": 0, "sector_story_count": 0, "story_count": 2, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 4, "confidence": 52, "evidence_status": "measured", "score_version": "evidence-v4", "newest_article_at": "2026-08-10T20:12:00+00:00", "label": "Constructive news tone", "tone": "positive"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 58, "events": [{"event": "earnings", "label": "Earnings", "weight": 0.6, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.6, "count": 1}], "positive_events": 2, "negative_events": 0, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "healthy", "calls_used": 40, "call_budget": 500, "budget_used_pct": 8.0, "requests_made": 8, "last_success_at": "2026-08-13T00:46:08.072252+00:00", "newest_seen_at": "2026-08-13T00:07:59+00:00", "rate_limit": 1200, "rate_remaining": 1198, "last_error": "", "mapped_mentions": 3604, "unmapped_mentions": 1784}, "status": "healthy"}}, "market_context": {"has_market_context": true, "latest_close": 293.15, "latest_week": "2026-08-07", "one_week_move": 2.0, "four_week_move": -7.3, "twelve_week_move": 37.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.846189, "market_dynamics_buy_signal": false, "relative_strength": 21.801237, "fair_value_gap": 120.7, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 58.1103, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.0% over one week, -7.3% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "News confirmed by price", "tone": "positive", "classification": "confirmed_positive", "summary": "Constructive news tone is being confirmed by positive weekly price action.", "confidence": 64, "badges": ["Sentiment confirms active trend", "Positive but stretched"], "opportunities": ["Constructive tone aligns with the Sharemaestro trend signal."], "risks": ["Constructive tone is arriving with price materially above fair value."], "event_label": "Earnings", "sentiment_word": "constructive"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "63/100", "tone": "positive", "text": "Constructive news tone"}, {"label": "Evidence confidence", "value": "52/100", "tone": "neutral", "text": "2.0 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "News confirmed by price", "tone": "positive", "text": "Constructive news tone is being confirmed by positive weekly price action."}, {"label": "Primary event", "value": "Earnings", "tone": "positive", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "4/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+2.0% over one week, -7.3% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates"}], "updated_at": "2026-08-13T00:50:50.370051+00:00", "detail_intelligence": {"headline": "News confirmed by price", "summary": "Constructive news tone is drawn from 2 fresh independent stories, including 2 company-specific items across 1 publishers.", "status": "measured", "metrics": [{"label": "Weighted tone", "value": 63, "display": "63", "tone": "positive", "note": "Constructive news tone"}, {"label": "Evidence confidence", "value": 52, "display": "52", "tone": "neutral", "note": "building confidence"}, {"label": "Company focus", "value": 100, "display": "100%", "tone": "positive", "note": "2 direct stories"}, {"label": "Evidence agreement", "value": 96, "display": "96", "tone": "positive", "note": "4/100 dispersion"}], "confidence_drivers": [{"label": "Sample depth", "value": 25, "note": "2.0 effective stories"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Direct relevance", "value": 100, "note": "company-specific evidence share"}, {"label": "Freshness", "value": 66, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 96, "note": "cross-story consistency"}, {"label": "Source independence", "value": 0, "note": "lower publisher concentration"}], "freshness": 66, "source_independence": 0, "timeline": [{"date": "2026-07-23", "label": "23 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 87.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 133.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 179.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 225.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 271.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 316.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 362.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 408.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 454.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 500.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 545.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 591.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 637.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 683.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 0, "score": null, "tone": "neutral", "x": 729.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 774.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 820.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 2, "score": 78, "tone": "positive", "x": 866.4, "y": 84.0, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 0, "score": null, "tone": "neutral", "x": 912.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "866.4,84.0", "timeline_has_signal": true, "timeline_start": "23 Jul", "timeline_mid": "02 Aug", "timeline_end": "12 Aug", "momentum": {"label": "Establishing", "tone": "neutral", "recent_score": 78, "prior_score": null, "delta": null, "recent_count": 2, "prior_count": 0, "volume_delta": 2}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 2, "share": 100}, {"label": "4 to 7 days", "count": 0, "share": 0}, {"label": "8 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 2, "share": 100, "score": 78, "tone": "positive"}], "event_profile": [{"label": "Deals and strategy", "count": 1, "share": 50, "score": 82, "tone": "positive"}, {"label": "Earnings", "count": 1, "share": 50, "score": 74, "tone": "positive"}], "topics": [{"label": "M A", "count": 1, "share": 50}, {"label": "Institutional Investors", "count": 1, "share": 50}, {"label": "Financial Results", "count": 1, "share": 50}, {"label": "Fda Approval", "count": 1, "share": 50}, {"label": "Earnings Per Share", "count": 1, "share": 50}, {"label": "Earnings", "count": 1, "share": 50}, {"label": "Debt Financing", "count": 1, "share": 50}, {"label": "Clinical Trials", "count": 1, "share": 50}, {"label": "Cardiovascular", "count": 1, "share": 50}, {"label": "Biotech", "count": 1, "share": 50}], "supporting": [{"label": "Direct evidence", "text": "2 current stories are mapped specifically to LGND."}, {"label": "Narrative agreement", "text": "Cross-story agreement is 96/100, indicating a comparatively coherent tape."}, {"label": "Price response", "text": "Constructive news tone is being confirmed by positive weekly price action."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}], "supporting_heading": "What supports the read", "tempering_heading": "What tempers the read", "latest_observation": {"title": "Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates", "summary": "Orchestra BioMed Holdings, Inc. The BACKBEAT global pivotal trial (\"BACKBEAT Trial\"), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable randomized patients by end of Q3 2026, with primary data presentation targeted for Q2 2027, assuming those endpoints are met. Virtue pivotal trial is advancing with further site activations and patient enrollments. $110 million cash balance provides projected runway into Q4 2027 and through key upcoming milestones, following $35 million in strategic capital from Medtronic and Ligand. Company to host R&D Day on November", "url": "https://finance.yahoo.com/healthcare/articles/orchestra-biomed-reports-second-quarter-201200454.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T20:12:00+00:00", "published_display": "10 Aug 2026 20:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.229, "duplicate_count": 1, "topics": ["Biotech", "Cardiovascular", "Clinical Trials", "Fda Approval", "Financial Results", "Institutional Investors"]}, "article_count": 2, "updated_at": "2026-08-12T23:39:45.275131+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 204.2, "label": "13 Feb 2026", "close": 183.83, "index": 100.0}, {"x": 77.4, "y": 204.0, "label": "20 Feb 2026", "close": 183.98, "index": 100.1}, {"x": 112.9, "y": 188.4, "label": "27 Feb 2026", "close": 198.31, "index": 107.9}, {"x": 148.3, "y": 184.4, "label": "06 Mar 2026", "close": 201.9, "index": 109.8}, {"x": 183.8, "y": 183.3, "label": "13 Mar 2026", "close": 202.91, "index": 110.4}, {"x": 219.2, "y": 181.3, "label": "20 Mar 2026", "close": 204.81, "index": 111.4}, {"x": 254.7, "y": 191.5, "label": "27 Mar 2026", "close": 195.48, "index": 106.3}, {"x": 290.1, "y": 187.0, "label": "03 Apr 2026", "close": 199.59, "index": 108.6}, {"x": 325.5, "y": 181.1, "label": "10 Apr 2026", "close": 204.92, "index": 111.5}, {"x": 361.0, "y": 151.7, "label": "17 Apr 2026", "close": 231.82, "index": 126.1}, {"x": 396.4, "y": 152.3, "label": "24 Apr 2026", "close": 231.27, "index": 125.8}, {"x": 431.9, "y": 156.5, "label": "01 May 2026", "close": 227.44, "index": 123.7}, {"x": 467.3, "y": 163.1, "label": "08 May 2026", "close": 221.41, "index": 120.4}, {"x": 502.8, "y": 172.1, "label": "15 May 2026", "close": 213.21, "index": 116.0}, {"x": 538.2, "y": 154.4, "label": "22 May 2026", "close": 229.33, "index": 124.8}, {"x": 573.6, "y": 151.6, "label": "29 May 2026", "close": 231.96, "index": 126.2}, {"x": 609.1, "y": 146.1, "label": "05 Jun 2026", "close": 237.0, "index": 128.9}, {"x": 644.5, "y": 125.8, "label": "12 Jun 2026", "close": 255.54, "index": 139.0}, {"x": 680.0, "y": 104.6, "label": "19 Jun 2026", "close": 274.88, "index": 149.5}, {"x": 715.4, "y": 73.3, "label": "26 Jun 2026", "close": 303.59, "index": 165.1}, {"x": 750.9, "y": 55.8, "label": "03 Jul 2026", "close": 319.55, "index": 173.8}, {"x": 786.3, "y": 59.4, "label": "10 Jul 2026", "close": 316.24, "index": 172.0}, {"x": 821.7, "y": 73.5, "label": "17 Jul 2026", "close": 303.39, "index": 165.0}, {"x": 857.2, "y": 76.6, "label": "24 Jul 2026", "close": 300.53, "index": 163.5}, {"x": 892.6, "y": 90.8, "label": "31 Jul 2026", "close": 287.54, "index": 156.4}, {"x": 928.1, "y": 84.7, "label": "07 Aug 2026", "close": 293.15, "index": 159.5}], "sentiment_points": [{"x": 701.4, "y": 120.8, "label": "23 Jun 2026", "score": 55}, {"x": 706.9, "y": 120.8, "label": "24 Jun 2026", "score": 55}, {"x": 709.2, "y": 120.8, "label": "24 Jun 2026", "score": 55}, {"x": 709.5, "y": 120.8, "label": "24 Jun 2026", "score": 55}, {"x": 710.5, "y": 120.8, "label": "25 Jun 2026", "score": 55}, {"x": 712.8, "y": 120.8, "label": "25 Jun 2026", "score": 55}, {"x": 713.1, "y": 120.8, "label": "25 Jun 2026", "score": 55}, {"x": 717.0, "y": 120.8, "label": "26 Jun 2026", "score": 55}, {"x": 717.5, "y": 120.8, "label": "26 Jun 2026", "score": 55}, {"x": 717.7, "y": 120.8, "label": "26 Jun 2026", "score": 55}, {"x": 720.5, "y": 122.6, "label": "27 Jun 2026", "score": 54}, {"x": 721.1, "y": 122.6, "label": "27 Jun 2026", "score": 54}, {"x": 722.2, "y": 122.6, "label": "27 Jun 2026", "score": 54}, {"x": 722.8, "y": 120.8, "label": "27 Jun 2026", "score": 55}, {"x": 723.1, "y": 120.8, "label": "27 Jun 2026", "score": 55}, {"x": 731.8, "y": 120.8, "label": "29 Jun 2026", "score": 55}, {"x": 733.9, "y": 120.8, "label": "29 Jun 2026", "score": 55}, {"x": 737.5, "y": 122.6, "label": "30 Jun 2026", "score": 54}, {"x": 746.1, "y": 122.6, "label": "02 Jul 2026", "score": 54}, {"x": 751.8, "y": 122.6, "label": "03 Jul 2026", "score": 54}, {"x": 753.4, "y": 122.6, "label": "03 Jul 2026", "score": 54}, {"x": 754.0, "y": 130.0, "label": "03 Jul 2026", "score": 50}, {"x": 762.2, "y": 122.6, "label": "05 Jul 2026", "score": 54}, {"x": 764.0, "y": 122.6, "label": "05 Jul 2026", "score": 54}, {"x": 780.5, "y": 120.8, "label": "08 Jul 2026", "score": 55}, {"x": 783.5, "y": 120.8, "label": "09 Jul 2026", "score": 55}, {"x": 786.6, "y": 122.6, "label": "10 Jul 2026", "score": 54}, {"x": 789.4, "y": 122.6, "label": "10 Jul 2026", "score": 54}, {"x": 789.5, "y": 122.6, "label": "10 Jul 2026", "score": 54}, {"x": 789.8, "y": 122.6, "label": "10 Jul 2026", "score": 54}, {"x": 791.2, "y": 122.6, "label": "10 Jul 2026", "score": 54}, {"x": 792.3, "y": 122.6, "label": "11 Jul 2026", "score": 54}, {"x": 794.3, "y": 122.6, "label": "11 Jul 2026", "score": 54}, {"x": 810.7, "y": 122.6, "label": "14 Jul 2026", "score": 54}, {"x": 825.6, "y": 120.8, "label": "17 Jul 2026", "score": 55}, {"x": 826.9, "y": 120.8, "label": "18 Jul 2026", "score": 55}, {"x": 832.9, "y": 120.8, "label": "19 Jul 2026", "score": 55}, {"x": 833.1, "y": 120.8, "label": "19 Jul 2026", "score": 55}, {"x": 838.7, "y": 120.8, "label": "20 Jul 2026", "score": 55}, {"x": 856.3, "y": 120.8, "label": "23 Jul 2026", "score": 55}, {"x": 856.7, "y": 120.8, "label": "23 Jul 2026", "score": 55}, {"x": 858.1, "y": 120.8, "label": "24 Jul 2026", "score": 55}, {"x": 865.0, "y": 122.6, "label": "25 Jul 2026", "score": 54}, {"x": 866.3, "y": 122.6, "label": "25 Jul 2026", "score": 54}, {"x": 866.7, "y": 122.6, "label": "25 Jul 2026", "score": 54}, {"x": 872.4, "y": 122.6, "label": "27 Jul 2026", "score": 54}, {"x": 889.7, "y": 122.6, "label": "30 Jul 2026", "score": 54}, {"x": 893.1, "y": 122.6, "label": "31 Jul 2026", "score": 54}, {"x": 895.4, "y": 120.8, "label": "31 Jul 2026", "score": 55}, {"x": 903.1, "y": 122.6, "label": "02 Aug 2026", "score": 54}, {"x": 905.4, "y": 120.8, "label": "02 Aug 2026", "score": 55}, {"x": 958.0, "y": 117.1, "label": "12 Aug 2026", "score": 57}], "price_path": "42.0,204.2 77.4,204.0 112.9,188.4 148.3,184.4 183.8,183.3 219.2,181.3 254.7,191.5 290.1,187.0 325.5,181.1 361.0,151.7 396.4,152.3 431.9,156.5 467.3,163.1 502.8,172.1 538.2,154.4 573.6,151.6 609.1,146.1 644.5,125.8 680.0,104.6 715.4,73.3 750.9,55.8 786.3,59.4 821.7,73.5 857.2,76.6 892.6,90.8 928.1,84.7", "sentiment_path": "701.4,120.8 706.9,120.8 709.2,120.8 709.5,120.8 710.5,120.8 712.8,120.8 713.1,120.8 717.0,120.8 717.5,120.8 717.7,120.8 720.5,122.6 721.1,122.6 722.2,122.6 722.8,120.8 723.1,120.8 731.8,120.8 733.9,120.8 737.5,122.6 746.1,122.6 751.8,122.6 753.4,122.6 754.0,130.0 762.2,122.6 764.0,122.6 780.5,120.8 783.5,120.8 786.6,122.6 789.4,122.6 789.5,122.6 789.8,122.6 791.2,122.6 792.3,122.6 794.3,122.6 810.7,122.6 825.6,120.8 826.9,120.8 832.9,120.8 833.1,120.8 838.7,120.8 856.3,120.8 856.7,120.8 858.1,120.8 865.0,122.6 866.3,122.6 866.7,122.6 872.4,122.6 889.7,122.6 893.1,122.6 895.4,120.8 903.1,122.6 905.4,120.8 958.0,117.1", "price_change": 59.5, "sentiment_change": 2, "latest_close": 293.15, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug"}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}